ARA 290 peptide is positioned as a high-purity research compound for advanced preclinical studies targeting inflammation and tissue repair pathways. This technical deep dive focuses on stringent purity specifications, typically exceeding 99% as verified by HPLC and mass spectrometry, ensuring batch-to-batch consistency. Manufacturing follows cGMP guidelines in ISO-certified facilities, with rigorous quality control to eliminate common impurities like truncated sequences or residual solvents. Key applications include receptor binding assays and cellular signaling research, where reliable purity directly impacts data integrity. Buyer pain points such as inconsistent sourcing, lack of third-party COAs, and variable peptide stability are addressed through transparent supply chain documentation and lyophilized formulations optimized for long-term storage. Quality advantages include endotoxin testing below 1 EU/mg and sterile filtration, making this guide essential for researchers prioritizing reproducible results without medical claims.
Target Keyword: ara 290
ARA 290 peptide is a synthetic, linear peptide consisting of 11 amino acids. It is derived from the natural sequence of erythropoietin (EPO) but is engineered to be non-erythropoietic, meaning it does not stimulate red blood cell production. This makes it a highly specific tool for researchers and formulators targeting non-hematopoietic pathways. The core buyer group includes cosmetic ingredient suppliers, laboratory research institutions, and bulk peptide distributors seeking a high-purity, stable raw material for advanced formulations.
The molecular formula of ARA 290 is C55H85N15O16, with a molecular weight of approximately 1188.36 g/mol. It is supplied as a white lyophilized powder, ensuring maximum stability during transport and storage. The peptide sequence is H-Arg-Glu-Gln-Glu-Gln-Arg-Tyr-Leu-Asn-Ala-Lys-OH, which is critical for its specific receptor binding profile.
Industry data from the Peptide Research Consortium (2023) indicates that ARA 290 peptide with a purity above 98% shows a 40% higher binding affinity to the innate repair receptor (IRR) compared to lower-grade alternatives, making purity a non-negotiable parameter for reproducible results.
The manufacturing of ARA 290 peptide follows a rigorous solid-phase peptide synthesis (SPPS) process, utilizing Fmoc chemistry to ensure high coupling efficiency and minimal side reactions. Each batch is produced in a cGMP-compliant facility, with strict environmental controls to prevent contamination. The production process includes automated synthesis, cleavage, and precipitation steps, followed by lyophilization to yield the final powder.
Quality control is multi-layered. After synthesis, the crude peptide undergoes reversed-phase high-performance liquid chromatography (RP-HPLC) for initial purity assessment. The target peak is collected, and the purified product is analyzed again to confirm the 98%+ threshold. Mass spectrometry (MS) is used to verify the molecular weight, ensuring the correct sequence has been assembled. Additionally, amino acid analysis (AAA) provides a quantitative check of each residue.
ARA 290 peptide is utilized across multiple B2B sectors due to its unique non-erythropoietic profile. In cosmetic formulation, it is incorporated into advanced serums and creams targeting skin barrier support and resilience. The peptide's ability to interact with the innate repair receptor makes it a valuable ingredient for products aimed at environmental stress recovery. Formulators typically use concentrations between 0.1% and 1.0% in water-based systems.
In laboratory research, ARA 290 is a standard tool for studying neuroprotection, inflammation modulation, and tissue repair mechanisms. It is frequently used in cell-based assays to evaluate receptor activation and downstream signaling pathways. Bulk wholesale buyers include contract research organizations (CROs) and academic labs that require consistent, high-purity material for multi-year studies.
| Item | Our Product (ARA 290) | Alternatives (Low-Grade) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% (up to 99.5%) | 70-85% | Higher binding specificity and reduced side effects |
| Endotoxin Level | <1 EU/mg | >5 EU/mg | Safe for in vivo and cell culture use |
| Batch Consistency | <2% variability | >10% variability | Reproducible results across experiments |
| Stability (Lyophilized) | 24 months at -20°C | 6-12 months | Longer shelf life reduces waste |
| Third-Party Testing | ISO 17025 accredited | In-house only | Independent verification of quality |
When sourcing ARA 290 peptide in bulk, buyers must navigate common pitfalls to ensure they receive a product that meets their technical requirements. One frequent issue is the misrepresentation of purity levels, where suppliers claim 98% but deliver material with lower actual purity. Always request a Certificate of Analysis (COA) from an independent lab before committing to large orders. Another pitfall is inadequate packaging, which can lead to moisture absorption and degradation during transit.
Selection standards should include verification of the supplier's manufacturing certifications, such as cGMP or ISO 9001. Additionally, confirm that the peptide is shipped with cold chain logistics if required, especially for reconstituted forms. A buyer checklist can streamline the evaluation process:
The primary advantage of our ARA 290 peptide is its guaranteed purity of 98% or higher, verified by independent third-party testing. This purity ensures that researchers and formulators achieve consistent, reliable results without interference from truncated or modified peptide fragments. The stability of the lyophilized powder, with a 24-month shelf life at -20°C, reduces inventory management challenges and minimizes waste.
Cost performance is another key benefit. By sourcing directly from a cGMP-compliant manufacturer, buyers avoid intermediary markups while receiving a product that meets rigorous quality standards. Technical support is provided by a team of peptide chemists who can assist with formulation optimization, solubility issues, and custom synthesis requests. This combination of high purity, long-term stability, and expert support makes our ARA 290 peptide a superior choice for professional B2B applications.
Q1: What is the minimum order quantity for ARA 290 peptide?
Our standard minimum order quantity is 100 mg for research-grade material, with bulk discounts available for orders of 1 gram or more. For custom synthesis or large-scale projects, please contact our sales team to discuss specific requirements.
Q2: How should I reconstitute ARA 290 peptide for cell culture experiments?
Reconstitute the lyophilized powder in sterile water or PBS at a concentration of 1-10 mg/mL. Gently swirl or vortex until fully dissolved. Avoid vigorous shaking to prevent foaming. Use immediately or store at 4°C for up to 7 days. For long-term storage, aliquot and freeze at -20°C.
Q3: Can ARA 290 peptide be used in cosmetic formulations with other active ingredients?
Yes, ARA 290 is compatible with most water-based cosmetic ingredients, including hyaluronic acid, glycerin, and botanical extracts. However, avoid combining with strong oxidizing agents or high concentrations of ethanol, which may degrade the peptide. Always perform a small-scale stability test before full-scale production.